Whereas Viking Therapeutics saw its shares fly due to favorable phase 2 trial results with its lead candidate, Terns is ...

The novel drugs work by mimicking the gut hormone GLP-1, which lowers blood sugar and limits the appetite. Treatments such as ...

EBGLYSS provides a new first-line biologic treatment for moderate-to-severe atopic dermatitis that is not well controlled with topicals ...

Bengaluru: Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and ...

Bridgewater Associates slashed a stake in Apple, halved its Lilly investment, doubled down on Microsoft, and bought Moderna ...

London: Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely ...

Drew, a 36-year-old man from San Antonio, Texas, drove more than 250 miles to Mexico to buy cheap Ozempic to help him lose ...

Market watchers, throughout the week, observed several Wall Street executives stepping up for new roles as part of leadership reshuffling.

The latest generation of weight-loss drugs—the likes of Wegovy, Ozempic and Maunjaro from the stables of Novo Nordisk and ...

The findings, in which doublet immunotherapy added to standard FOLFOX chemotherapy did not improve progression-free survival, ...

A new prescription drug in the battle against obesity has this week been approved by Australian regulators, with experts ...

The lack of a disease-free survival benefit with adjuvant durvalumab in early-stage resected non-small cell lung cancer in ...